Specific hybridoma cell line and monocolonal antibodies produced

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 7, 43524027, 4351722, 436548, 436538, 436542, 436518, 436527, 436531, 935104, 935106, 935107, 935110, 530395, 530809, 530828, A61K 39395, C07K 1514, C12N 1500, G01N 33574

Patent

active

048733130

ABSTRACT:
A specific hybridoma cell line produces monoclonal antibodies which are effective in detecting carcinoembryonic antigens (CEA). The specific hydribome line and monoclonal antibodes are designated as T84.66-A3.1-H11. The monoclonal antibodies are preferably applied to tissues and fluids to detect the degree of binding of such monoclonal antibodies to such carcinoembryonic antigens.

REFERENCES:
patent: 4348378 (1982-09-01), Goldenberg
patent: 4359528 (1982-09-01), Koprowski
patent: 4467031 (1984-08-01), Gallati
Wagener, C. et al., Journal of Immunology, 130(5):2308-2315 (5-1983).
Wagener, C. et al, Journal of Immunology, 130(5):2302-2307 (5-1985).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Specific hybridoma cell line and monocolonal antibodies produced does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Specific hybridoma cell line and monocolonal antibodies produced, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific hybridoma cell line and monocolonal antibodies produced will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1958318

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.